H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 45 Citations 8,098 114 World Ranking 2666 National Ranking 223

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Bacteria
  • Immune system

Mark J. Taylor mainly focuses on Wolbachia, Immunology, Onchocerciasis, Microbiology and Filariasis. His Wolbachia study incorporates themes from Nematode, Brugia malayi, Rickettsiales and Virology. Mark J. Taylor is interested in Diethylcarbamazine, which is a branch of Immunology.

His Onchocerciasis research includes themes of Ivermectin, Doxycycline, Helminthiasis and Lymphatic filariasis. He studied Doxycycline and Antibacterial agent that intersect with Physiology. His Physiology study combines topics in areas such as BECN1, Onchocerca, Computational biology, Programmed cell death and Anthelmintic.

His most cited work include:

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
  • Lymphatic filariasis and onchocerciasis. (430 citations)
  • The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness (311 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Wolbachia, Immunology, Onchocerciasis, Lymphatic filariasis and Microbiology. His Wolbachia research is multidisciplinary, incorporating perspectives in Virology, Filariasis, Brugia malayi, Doxycycline and Nematode. His studies deal with areas such as Regimen, Internal medicine, Antibacterial agent and Pharmacology as well as Doxycycline.

Mark J. Taylor has researched Onchocerciasis in several fields, including Macrofilaricide and Ivermectin. His studies in Lymphatic filariasis integrate themes in fields like Wuchereria bancrofti, Lymphatic system, Diethylcarbamazine and Neglected tropical diseases. His Microbiology research is multidisciplinary, incorporating elements of Inflammation and Rickettsiales, Intracellular parasite, Bacteria.

He most often published in these fields:

  • Wolbachia (37.95%)
  • Immunology (35.90%)
  • Onchocerciasis (28.21%)

What were the highlights of his more recent work (between 2017-2021)?

  • Lymphatic filariasis (23.08%)
  • Wolbachia (37.95%)
  • Onchocerciasis (28.21%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Lymphatic filariasis, Wolbachia, Onchocerciasis, Brugia malayi and Doxycycline. His work carried out in the field of Lymphatic filariasis brings together such families of science as Internal medicine, Lymphatic system, Neglected tropical diseases and Podoconiosis. His research in Wolbachia intersects with topics in Virology, Biotechnology, Phenotypic screening, Filariasis and Nematode.

His Onchocerciasis research integrates issues from Ivermectin, Rifampicin and Drug. His study in Brugia malayi is interdisciplinary in nature, drawing from both Trichuris trichiura, Microbiology, Anthelmintic and Heligmosomoides polygyrus. His work deals with themes such as Oral administration, Pharmacology, Brugia pahangi and In vivo, which intersect with Doxycycline.

Between 2017 and 2021, his most popular works were:

  • Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides (51 citations)
  • Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis. (32 citations)
  • AWZ1066S, a highly specific anti- Wolbachia drug candidate for a short-course treatment of filariasis (27 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Bacteria

Mark J. Taylor spends much of his time researching Wolbachia, Lymphatic filariasis, Onchocerciasis, Doxycycline and Brugia malayi. His Wolbachia study integrates concerns from other disciplines, such as Nematode, Antibiotic therapy, Antibiotics and Insect. His Lymphatic filariasis study introduces a deeper knowledge of Filariasis.

The Onchocerciasis study combines topics in areas such as Health economics, Vector, Ivermectin and Environmental health. He works mostly in the field of Doxycycline, limiting it down to concerns involving Pharmacology and, occasionally, Minocycline. His study on Brugia malayi is covered under Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)

6803 Citations

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)

4781 Citations

Lymphatic filariasis and onchocerciasis.

Mark J Taylor;Achim Hoerauf;Moses Bockarie.
The Lancet (2010)

623 Citations

The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness

Amélie v. Saint André;Nathan M. Blackwell;Laurie R. Hall;Achim Hoerauf.
Science (2002)

420 Citations

Wolbachia bacterial endosymbionts of filarial nematodes.

Mark J. Taylor;Claudio Bandi;Achim Hoerauf.
Advances in Parasitology (2005)

416 Citations

Wolbachia Bacteria of Filarial Nematodes

M.J Taylor;A Hoerauf.
Parasitology Today (1999)

395 Citations

Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial

Mark J Taylor;Williams H Makunde;Williams H Makunde;Helen F McGarry;Joseph D Turner.
The Lancet (2005)

345 Citations

Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria.

Mark J. Taylor;Helen F. Cross;Katja Bilo.
Journal of Experimental Medicine (2000)

345 Citations

Mass drug treatment for lymphatic filariasis and onchocerciasis.

David H Molyneux;Mark Bradley;Achim Hoerauf;Dominique Kyelem.
Trends in Parasitology (2003)

296 Citations

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study

Achim Hoerauf;Sabine Specht;Marcelle Büttner;Kenneth Pfarr.
Medical Microbiology and Immunology (2008)

259 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark J. Taylor

Achim Hoerauf

Achim Hoerauf

University Hospital Bonn

Publications: 128

Thomas B. Nutman

Thomas B. Nutman

National Institutes of Health

Publications: 74

Mark Blaxter

Mark Blaxter

Wellcome Sanger Institute

Publications: 38

Claudio Bandi

Claudio Bandi

University of Milan

Publications: 36

Daniel J. Klionsky

Daniel J. Klionsky

University of Michigan–Ann Arbor

Publications: 33

Moses J. Bockarie

Moses J. Bockarie

European & Developing Countries Clinical Trials Partnership

Publications: 32

Seth R. Bordenstein

Seth R. Bordenstein

Vanderbilt University

Publications: 32

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 31

Thomas R. Unnasch

Thomas R. Unnasch

University of South Florida

Publications: 30

Eric Pearlman

Eric Pearlman

Case Western Reserve University

Publications: 27

Saeid Ghavami

Saeid Ghavami

University of Manitoba

Publications: 25

Sergio Lavandero

Sergio Lavandero

University of Chile

Publications: 25

Patrice Codogno

Patrice Codogno

Université Paris Cité

Publications: 24

Scott Leslie O'Neill

Scott Leslie O'Neill

Monash University

Publications: 24

Steven A. Williams

Steven A. Williams

Smith College

Publications: 23

Timothy G. Geary

Timothy G. Geary

McGill University

Publications: 22

Something went wrong. Please try again later.